![Jean-Luc Samuel Francois Girardet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Luc Samuel Francois Girardet
Direttore Tecnico/Scientifico/R&S presso MIRUM PHARMACEUTICALS, INC.
Profilo
Jean-Luc Samuel Francois Girardet is currently the Senior Vice President-Pharmaceutical Sciences at Brii Biosciences Ltd.
(China) since 2018.
He is also currently the Senior Vice President-Technical Operations at Mirum Pharmaceuticals, Inc. Previously, Dr. Girardet worked as the Vice President-Research Operations at Ardea Biosciences, Inc. Dr. Girardet completed his undergraduate degree in 1991 and his doctorate degree in 1995 from Université de Montpellier.
Posizioni attive di Jean-Luc Samuel Francois Girardet
Società | Posizione | Inizio |
---|---|---|
BRII BIOSCIENCES LIMITED | Corporate Officer/Principal | 19/03/2018 |
MIRUM PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Jean-Luc Samuel Francois Girardet
Società | Posizione | Fine |
---|---|---|
Ardea Biosciences, Inc.
![]() Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | - |
Formazione di Jean-Luc Samuel Francois Girardet
Université de Montpellier | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BRII BIOSCIENCES LIMITED | Commercial Services |
MIRUM PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Ardea Biosciences, Inc.
![]() Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Health Technology |
- Borsa valori
- Insiders
- Jean-Luc Samuel Francois Girardet